Researchers
Zarić, Bojan
Results 21-40 of 220
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2023 | Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non–Small-Cell Lung Cancer: Results From LASER301![]() | Cho, Byoung Chul; Ahn, Myung-Ju; Kang, Jin Hyoung; Soo, Ross A.; Reungwetwattana, Thanyanan; Yang, James Chih-Hsin; Cicin, Irfan; Kim, Dong-Wan; Wu, Yi-Long; Lu, Shun; | Article | 21a+M21a+ |
| 2023 | Improving the Lives of Patients Diagnosed with Lung Carcinoma: The Holistic Power of Palliative Care![]() | Kovacevic, Tomi | Conference Paper | Mp. category will be shown later |
| 2023 | Real-world data on survival outcomes and characteristics of lung cancer patients in northern serbia.![]() | Bokan, Darijo | Conference Paper | Mp. category will be shown later |
| 2023 | Management of paresthesia in patients treated with lazertinib: Integrated analysis of LASER201 and LASER301 studies![]() | Lee, Y-G; ...; Zaric, B | Conference Paper | Mp. category will be shown later |
| 2023 | Results and challenges of lung cancer screening in Serbia![]() | Djekic-Malbasa, Jelena | Conference Paper | Mp. category will be shown later |
| 2022 | Predicting 30-Day Readmission Risk for Patients With Chronic Obstructive Pulmonary Disease Through a Federated Machine Learning Architecture on Findable, Accessible, Interoperable, and Reusable (FAIR) Data: Development and Validation Study![]() | Alvarez-Romero, Celia; ...; Kovacevic, Tomi S | Article | 22M22 |
| 2022 | A randomized, double-blind, multinational phase III study to assess the efficacy and safety of lazertinib versus gefitinib in the first-line treatment of patients with EGFR mutation (EGFRm), advanced NSCLC (LASER301; NCT04248829)![]() | Cho, BC; ...; Zaric, Bojan | Conference Paper | Mp. category will be shown later |
| 2022 | Pilot lung cancer screening program results in Serbia during 1-year period![]() | Djekic-Malbasa, Jelena N | Conference Paper | Mp. category will be shown later |
| 2022 | Lung cancer epidemiology and survival outcomes in Vojvodina, Serbia![]() | Bokan, Darijo | Conference Paper | Mp. category will be shown later |
| 2022 | "One Shot" Sample Evaluation of 22G, 22G upgraded, 21G and 19G needle for Endobronchial Ultrasound-EBUS-TBNA![]() | Oikonomidou, Rena; ...; Zaric, Bojan | Article | 22M22 |
| 2022 | Mortality of COVID-19 pneumonia during anticancer treatment in lung cancer patients![]() | Bursac, Daliborka S | Article | 23M23 |
| 2022 | Cryo-Biopsy versus 19G needle versus 22G needle with EBUS-TBNA endoscopy![]() | Oikonomidou, Rena; ...; Zaric, Bojan | Article | 22M22 |
| 2022 | Epidemiology of Lung Cancer in Northern Serbia During the Past Ten Years![]() | Djekic-Malbasa, Jelena N | Conference Paper | Mp. category will be shown later |
| 2022 | Burn-out syndrome: neglected syndrome among health care professionals managing lung care patients.![]() | Kovačević, Tomi | Conference Paper | Mp. category will be shown later |
| 2022 | Lung Cancer in Serbia![]() | Čavić Milena | Article | 21a+M21a+ |
| 2022 | Interna medicina - [Knj.] 1 - Pulmologija, kardiologija![]() | Bursać, Daliborka | Text book | Mp. category will be shown later |
| 2022 | Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer![]() | Spasić, Jelena | Article | 22M22 |
| 2022 | Managing patients with respiratory diseases: burnout among HCP![]() | Kovacevic, Tomi S | Conference Paper | Mp. category will be shown later |
| 2021 | A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment![]() | Saif Muhammad, Wasif; ...; Popovic, Lazar S | Article | 22M22 |
| 2021 | Bevacizumab biosimilar (MB02) and reference bevacizumab in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) (STELLA study): Multiple Imputation analysis.![]() | Trukhin, Dmytro; Poddubskaya, Elena; Andric, Zoran G
Garcia, Fernanda;
| Conference Paper | Mp. category will be shown later |
